Fast Facts: Heart Failure

Dariusz Korczyk, Gerry Kaye, D. Korczyk, G. Kaye

• Publisher: S. Karger
• Year: 2022
• Print ISBN: 9783318069884
• eBook ISBN: 9783318069891
• Topic: Medicine
• Subtopic: Cardiology

A better understanding of the mechanisms and pathophysiological pathways of heart failure (HF), improved management of associated comorbidities, and advances in identifying genetic cardiac disease have led to a near-revolution in the management of patients in terms of pharmacological treatments, surgery and devices. These developments have transformed outcomes and HF-associated mortality, and gene therapies further promise a brighter future for patients who experience the debilitating effects of HF. This new edition of 'Fast Facts: Heart Failure' starts with the definitions of HF (different types of HF require different treatments), then provides the latest thinking on mechanisms and clinical stages, underlying causes and the assessment and management of comorbidities. This is followed by simple diagnostic criteria and a comprehensive overview of investigations. The management chapters focus on the importance of self-care education and healthy lifestyle choices, together with the latest recommendations for pharmacological treatment, device therapy and cardiac surgery from international guidelines. The final chapter on developments is an indication of the ongoing innovation in this rapidly moving field.

INDEX

ACC/AHA stage 12

ACEIs (angiotensin-converting enzyme inhibitors) 61, 80, 118, 122–3

acetazolamide 133

acoramidis 116

acute HF 15, 18–19, 89, 90–3, 111

management 138–40, 192

acute ischemic hepatitis 81

acute kidney injury 79

adherence 62, 101–2

advanced health directives 185–7

advanced HF 29, 170–7, 181–8

age 14, 17, 42–3, 119, 129, 175–6

air travel 110–12

alcohol use 108

aldosterone 25

aldosterone antagonists 116, 119, 129–31, 138, 194–5

amyloidosis 48–50, 96, 116

analgesia 186

anemia 64, 72–5, 84, 133

angiography 57, 96

angiotensin I/II 25

anthracyclines 60

anticoagulants 136, 140

anti-emetics 186

anxiety 82–3, 187

aortic valve 38, 40, 66

ARBs (angiotensin receptor blockers) 61, 80, 118, 123–4

ARNIs (angiotensin receptor/neprilysin inhibitors) 118, 124–5, 192

arrhythmias

atrial 58, 63, 93, 117, 135, 159–60

ventricular 57–8, 93, 146–7, 160

arrhythmogenic cardiomyopathy (ACM) 45–8

arterial hypertension 20, 36–7, 64, 117

artificial hearts 173–4

atherosclerosis 34–5

athlete’s heart 58

atrial arrhythmias 58, 63, 93, 117, 135, 159–60

atrioventricular optimization 155

ATTR cardiac amyloidosis 49–50, 116

autonomic nervous system 26–7, 162–4

β-adrenoreceptor agonists 76, 194

beta-blockers 61, 77–8, 80, 118, 119, 125–9, 138

biomarker...

Table of contents

• Cover
• Title Page
• Copyright
• Contents
• Glossary and abbreviations
• Introduction
• Definitions, classification and epidemiology
• Pathophysiology and clinical stages
• Causes
• Comorbidities
• Diagnosis
• General management and lifestyle considerations
• Pharmacological treatment
• Non-pharmacological management
• Advanced HF therapies
• Prognosis
• Developments and future directions
• Useful resources
• Index